Grace Therapeutics, Inc. (GRCE) has 8 open-market insider trades by 2 insiders since 2026. Over the last six months insiders net bought $608K. The most active filer is Opaleye Management Inc., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | — | 7 | $394K | 2026-10-16 |
| Prashant Kohli | CEO | — | 1 | $214K | 2026-09-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | Buy | $136K | 2026-10-14 |
| Opaleye Management Inc. | 10% Owner | Buy | $30K | 2026-10-08 |
| Opaleye Management Inc. | 10% Owner | Buy | $124K | 2026-10-01 |
| Opaleye Management Inc. | 10% Owner | Buy | $16K | 2026-09-29 |
| Opaleye Management Inc. | 10% Owner | Buy | $32K | 2026-09-21 |
| Prashant Kohli | CEO | Buy | $214K |
Companies that share insiders with GRCE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-09-09 |
| Opaleye Management Inc. | 10% Owner | Buy | $32K | 2026-09-08 |
| Opaleye Management Inc. | 10% Owner | Buy | $24K | 2026-08-14 |